title: [NCCN Asian consensus statement - can Asian patients with cancer accept treatment modalities from NCCN guidelines ?].
abstract: To spread the National Comprehensive Cancer Network(NCCN)guidelines widely in Asia, committee members from Asian countries have been preparing an Asia Consensus Statement(ACS)along the NCCN guidelines. The ACS for Kidney Cancer guidelines and Prostate Cancer guidelines were issued in 2009 and in 2011, respectively. In addition, second versions of both these guidelines were issued in 2011 and 2013, respectively. In this review, the process and contents of NCCN ACS have been described.
authors.affiliation: Dept. of Urology, Hamamatsu University, School of Medicine.
authors.forename: Seiichiro
authors.initials: S
authors.lastname: Ozono
authors.forename: Shiro
authors.initials: S
authors.lastname: Hinotsu
authors.forename: Mikio
authors.initials: M
authors.lastname: Namiki
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Akaza
mesh_terms: D001208:Asia; D002986:Clinical Trials as Topic; D032921:Consensus; D006801:Humans; D007680:Kidney Neoplasms / Q000628:therapy*; D008297:Male; D017410:Practice Guidelines as Topic; D011471:Prostatic Neoplasms / Q000628:therapy*